Anika Therapeutics (ANIK) Short-term Investments: 2014-2025
Historic Short-term Investments for Anika Therapeutics (ANIK) over the last 10 years, with Sep 2025 value amounting to $22.2 million.
- Anika Therapeutics' Short-term Investments fell 21.76% to $22.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.2 million, marking a year-over-year decrease of 21.76%. This contributed to the annual value of $23.6 million for FY2024, which is 10.49% down from last year.
- Per Anika Therapeutics' latest filing, its Short-term Investments stood at $22.2 million for Q3 2025, which was down 7.38% from $24.0 million recorded in Q2 2025.
- Anika Therapeutics' Short-term Investments' 5-year high stood at $36.7 million during Q2 2023, with a 5-year trough of $22.0 million in Q1 2025.
- Its 3-year average for Short-term Investments is $28.6 million, with a median of $28.4 million in 2024.
- In the last 5 years, Anika Therapeutics' Short-term Investments skyrocketed by 1,093.24% in 2021 and then plummeted by 31.46% in 2025.
- Anika Therapeutics' Short-term Investments (Quarterly) stood at $29.8 million in 2021, then increased by 16.03% to $34.6 million in 2022, then declined by 23.87% to $26.4 million in 2023, then decreased by 10.49% to $23.6 million in 2024, then fell by 21.76% to $22.2 million in 2025.
- Its Short-term Investments stands at $22.2 million for Q3 2025, versus $24.0 million for Q2 2025 and $22.0 million for Q1 2025.